FDA and CDC announce authorization of booster doses of the Pfizer COVID-19 vaccine

September 24, 2021

Dear colleagues,

The Food and Drug Administration and Centers for Disease Control have now authorized COVID-19 booster doses of the Pfizer vaccine for individuals as follows:

  • Fully vaccinated with Pfizer vaccines only and six months have passed since receiving a second dose
  • Individuals 65 years of age and older
  • Individuals 18 through 64 years of age with any underlying condition
  • Individuals 18 through 64 years of age who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting, based on their individual benefits and risks

This authorization was provided following extensive research, which determined booster doses achieve heightened immunity against COVID-19. As a result of this guidance, Texas Children’s is now making booster doses available to all our team members beginning tomorrow at 7 a.m.

All Texas Children’s workforce members regardless of their job function, who have been fully vaccinated with Pfizer vaccines, and have received their second dose at least six months previously, can receive their booster dose at Texas Children’s. Receiving a booster dose is encouraged to provide further protection against COVID-19.

If you are eligible and would like to receive a Pfizer booster through Texas Children’s, please click here.

Additional Guidance
  • When receiving your booster, please bring your COVID-19 vaccination card to your appointment.
  • Lost your vaccine card? Please click here for guidance.
  • At this time, those who received the Moderna or Johnson & Johnson vaccines are not eligible for the booster dose. However, booster doses for those vaccines may be available in the near future.

If you have questions related to this new guidance, please contact our Vaccine Employee Support line at 832-VACCINE (832-822-2463).

Thank you for your attention and for your continued efforts to protect yourselves and our communities against COVID-19.